The Strategist in Brief: June 11, 2026

This week's episode covers proposed Medicaid payment caps, insights from chief physician executives, the medical student shortage, Eli Lilly's 340B ultimatum, and a court ruling on Medicare Advantage star ratings. 

Transcript

Anika 0:02

This is the Strategist in Brief for June 11th, 2026, your quick audio rundown of the top headlines from Strategy Catalyst's newsletter. Here's what strategy leaders should know this week The Centers for Medicare and Medicaid Services is proposing broader caps on Medicaid state-directed payments, significantly broader than those outlined in last year's budget reconciliation legislation, Which would reduce federal healthcare spending by five hundred and ten billion dollars over ten years The proposal would increase the financial impact of the One Big Beautiful Bill Act by roughly one-third, forcing health systems to accelerate strategic plans to fill the financial hole with outpatient growth, AI savings, and other internal transformations. Democratic lawmakers could try to reverse the cuts if they take control of Congress after the midterms, but advocacy efforts might be better targeted at the state level Discussions at a recent Health Management Academy forum showcased how chief physician executives are among strategy leaders' strongest allies for growth. But the issues they surface are architectural, not behavioral, requiring redesigning organizational structures rather than changing individual behavior. Access stalls because compensation models reward keeping low acuity patients on specialist schedules. Transforming the care model with greater advanced practice provider reliance requires changing the compensation model alongside it. governance lags the pace of deployment because it was built to manage risk, not capture value. The fastest systems separate clinical AI, which needs rigorous review from administrative AI, which can move through a faster lane. And physician well-being is an organizational design problem deserving a dedicated C-suite owner. Efficiency gains can backfire unless there's a clear answer for how recaptured physician time will be used This week's featured graphic shows that the US graduates eight point six medical students for every one hundred thousand people, far below the OECD average of nearly fifteen. A Commonwealth Fund report ties the gap to two upstream constraints: the highest medical tuition fees of any country in the analysis and limited residency training positions. Be sure to check out the full newsletter to see the graphic. Turning to three forty B, Eli Lilly is threatening to cut off three forty B discounts for hospitals that won't share claims data. Health systems that comply could face significant administrative burden while regulators stay on the sidelines. Eli Lilly says roughly 1,000 hospitals have refused, while more than 2,300 have complied, and it is starting enforcement with the largest non-responders The data could let manufacturers eliminate duplicate discounts, quantify hospitals' contract pharmacy spread, build the empirical case for narrowing 340B, and gain demand intelligence on high-value drugs The Health Resources and Services Administration has so far declined to block the policy despite American Hospital Association pressure to declare it unlawful. And finally, a federal judge's ruling for Clover Health ordering the Centers for Medicare and Medicaid Services to recalculate its Medicare Advantage star rating after finding twenty measures were improperly included reframes a routine scoring dispute as a challenge to CMS's authority over how Medicare Advantage quality is measured. If the reasoning survives appeal, it could force the program to drop measures that CMS still relies on, creating exposure for health systems running provider-sponsored health plans. That concludes this week's edition of The Strategist in Brief. Be sure to check out the full version on the web at hmacademy.com. Thanks for listening